The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement of macrophages.
D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum; D001202:Ascitic Fluid / Q000166:cytology; D001769:Blood; D002417:Cattle / Q000276:immunology; D002478:Cells, Cultured; D003911:Dextrans; D004140:Dinitrophenols; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005333:Fetus; D006801:Humans; D008239:Lysine; D008244:Lysophosphatidylcholines; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D009161:Mycobacterium / Q000276:immunology*; D010940:Plant Proteins; D011138:Polytetrafluoroethylene; D013154:Spleen / Q000166:cytology; D005719:gamma-Globulins
D000276:Adjuvants, Immunologic; D000961:Antilymphocyte Serum; D003911:Dextrans; D004140:Dinitrophenols; D008244:Lysophosphatidylcholines; D010940:Plant Proteins; D005719:gamma-Globulins; D011138:Polytetrafluoroethylene; D008239:Lysine